Baseline serum levels of cardiac biomarkers in patients with stable coronary artery disease

Biomarkers

Volumn 12, Issue 5, 2007, Pages 533-540

  Karacalioglu, O ^a   Arslan, Z ^a   Kilic, S ^a   Ozturk E ^a   Ozguven, M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Aspartate aminotransferase; CK MB mass; Creatine kinase (CK); Lactate dehydrogenase; Myoglobin; Tc 99m MIBI

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; CYTOPLASM PROTEIN; LACTATE DEHYDROGENASE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MYOGLOBIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE SEVERITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT REFERRAL; PROTEIN SECRETION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREADMILL EXERCISE;

ADULT; AGED; AGED, 80 AND OVER; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CREATINE KINASE; CREATINE KINASE, MB FORM; HEART VENTRICLES; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; MYOGLOBIN; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34548189500     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500701325237     Document Type: Article

References (31)

1. Ahmed, SA, Williamson, JR, Roberts, R., Clark, RE and Sobel, BE (1976) The association of increased plasma MB CPK activity and irreversible ischemic myocardial injury in the dog. Circulation, 54, pp. 187-193.
2. Apple, FS, Murakami, M., Panteghini, M., Christenson, RH, Dati, F. and Mair, J. (2001) IFCC Committee on Standardization of Markers of Cardiac Damage. International survey on the use of cardiac markers. Clinical Chemistry, 47, pp. 587-588.
3. Benoit, T., Vivegnis, D., Foulon, J. and Rigo, P. (1996) Quantitative evaluation of myocardial single-photon emission tomographic imaging: application to the measurement of perfusion defect size and severity. European Journal of Nuclear Medicine, 23, pp. 1603-1612.
4. Berman, DS, Hachamovitch, R., Kiat, H., Cohen, I., Cabico, JA and Wang, FP (1995) Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. Journal of the American College of Cardiology, 26, pp. 639-647.
5. Cavallini, C., Rugolotto, M. and Savonitto, S. (2005) Prognostic significance of creatine kinase release after percutaneous coronary intervention. Italian Heart Journal, 6, pp. 522-529.
6. Collinson, PO (2000) Cardiac markers into the new millennium. Annals of Clinical Biochemistry, 37, pp. 109-113.
7. Germano, G., Kiat, H., Kavanagh, PB, Moriel, M., Mazzanti, M. and Su, HT (1995) Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. Journal of Nuclear Medicine, 36, pp. 2138-2147.
8. Heyndrickx, GR, Amano, J., Kenna, T., Fallon, JT, Patrick, TA and Manders, WT (1985) Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. Journal of Molecular & Cell Cardiology, 6, pp. 1299-1303.
9. Ishikawa, Y., Saffitz, JE, Mealman, TL, Grace, AM and Roberts, R. (1997) Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma. Clinical Chemistry, 43, pp. 467-475.
10. Kang, X., Van Train, K. and Lewin, HC (1997) Prognostic value of automatic quantitative defect extent, severity and reversibility in exercise myocardial perfusion SPECT: Comparison with visual analysis. Journal of Nuclear Medicine, 38, p. 53P.
11. Maddahi, J., Van Train, K., Prigent, F., Garcia, EV, Friedman, J. and Ostrzega, E. (1989) Quantitative single photon emission computed thallium-201 tomography for detection and localization of coronary artery disease: Optimization and prospective validation of a new technique. Journal of the American College of Cardiology, 14, pp. 1689-1699.
12. Mair, J. (1999) Tissue release of cardiac markers: From physiology to clinical applications. Clinical Chemistry & Laboratory Medicine, 37, pp. 1077-1084.
13. Michael, LH, Hunt, JR, Weilbaecher, D., Perryman, MB, Roberts, R. and Lewis, RM (1985) Creatine kinase and phosphorylase in cardiac lymph: coronary occlusion and reperfusion. American Journal of Physiology, 248, pp. 350-359.
14. Panteghini, M., Apple, FS, Christenson, RH, Dati, F., Mair, J. and Wu, AH (1999) Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry. Clinical Chemistry Laboratory Medicine, 37, pp. 687-693.
15. Piper, HM, Schwartz, P., Spahr, R., Hutter, JF and Spieckermann, PG (1984) Early enzyme release from myocardial cells is not due to irreversible cell damage. Journal of Molecular & Cell Cardiology, 16, pp. 385-388.
16. Razek, HA, Erler, BS and Talley, JD (2000) Serial troponin I measurements detect recurrent myocardial infarction after initial acute myocardial infarction. Journal of the Arkansas Medical Society, 97, pp. 202-204.
17. Remppis, A., Scheffold, T., Greten, J., Haass, M., Greten, T. and Kubler, W. (1995) Intracellular compartmentation of troponin T: Release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. Journal of Molecular & Cell Cardiology, 27, pp. 793-803.
18. Roberts, R. and Fromm, RE (1998) Management of acute coronary syndromes based on risk stratification by biochemical markers: An idea whose time has come. Circulation, 98, pp. 1853-1859.
19. Sakai, K. and Spieckermann, PG (1975) Effects of reserpine and propranolol on anoxia-induced enzyme release from the isolated perfused guinea-pig-heart. Naunyn-Schmiedeberg's Archives of Pharmacology, 291, pp. 123-130.
20. Sharir, T., Germano, G., Waechter, PB, Kavanagh, PB, Areeda, JS and Gerlach, J. (2000) A new algorithm for the quantitation of myocardial perfusion SPECT. II. Validation and diagnostic yield. Journal of Nuclear Medicine, 41, pp. 720-727.
21. Sorichter, S., Mair, J., Koller, A., Calzolari, C., Huonker, M. and Pau, B. (2001) Release of muscle proteins after downhill running in male and female subjects. Scandinavian Journal of Medicine & Science in Sports, 11, pp. 28-32.
22. Spieckermann, PG, Nordbeck, H. and Preusse, CJ (1979) From heart to plasma. Enzymes in Cardiology, Diagnosis and Research, pp. 81-95. John Wiley and Sons, Belfast
23. Taillefer, R., Ahlberg, AW, Masood, Y., White, CM, Lamargese, I. and Mather, JF (2003) Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. Journal of the American College of Cardiology, 42, pp. 1475-1483.
24. Turer, AT, Mahaffey, KW, Gallup, D., Weaver, WD, Christenson, RH and Every, NR (2005) Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction. Current Control Trials Cardiovascular Medicine, 23, pp. 6-12.
25. Van Train, KF, Areeda, J., Garcia, EV, Cooke, CD, Maddahi, J. and Kiat, H. (1993) Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: Definition and validation of stress normal limits and criteria for abnormality. Journal of Nuclear Medicine, 34, pp. 1494-1502.
26. Voss, EM, Sharkey, SW, Gernert, AE, Murakami, MM, Johnston, RB and Hsieh, CC (1995) Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium. Infarct sizing using serum profiles. Archives of Pathology & Laboratory Medicine, 119, pp. 799-806.
27. Wienen, W. and Kammermeier, H. (1988) Intra- and extracellular markers in interstitial transudate of perfused rat hearts. American Journal of Physiology, 254, pp. 785-794.
28. Wiviott, SD, Cannon, CP, Morrow, DA, Murphy, SA, Gibson, CM and McCabe, CH (2004) Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation, 109, pp. 565-567.
29. Wu, AHB (1999) Biochemical markers of cardiac damage: From traditional enzymes to cardiac-specific proteins. Scandinavian Journal of Clinical & Laboratory Investigation, 59, pp. 74-82.
30. Wu, AH and Ford, L. (1999) Release of cardiac troponin in acute coronary syndromes: Ischemia or necrosis?. Clinica Chimica Acta, 284, pp. 161-174.
31. Yoshioka, J., Hasegawa, S., Yamaguchi, H., Tokita, N., Paul, AK and Xiuli, M. (1999) Left ventricular volumes and ejection fraction calculated from quantitative electrocardiographic-gated 99mTc-teterofosmin myocardial SPECT. Journal of Nuclear Medicine, 40, pp. 1693-1698.